相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial
Douglas S. Goodin et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
Ralf A. Linker et al.
BRAIN (2011)
Interferon β-1b and glatiramer acetate effects on permanent black hole evolution
M. Filippi et al.
NEUROLOGY (2011)
Pathway Commons, a web resource for biological pathway data
Ethan G. Cerami et al.
NUCLEIC ACIDS RESEARCH (2011)
Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease
Gisa Ellrichmann et al.
PLOS ONE (2011)
Is multiple sclerosis a mitochondrial disease?
Peizhong Mao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Innovations driving biomarker evaluation and use
John A. Wagner
BIOMARKERS IN MEDICINE (2010)
The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
Antonio Scalfari et al.
BRAIN (2010)
Glatiramer Acetate A Review of its Use in Relapsing-Remitting Multiple Sclerosis and in Delaying the Onset of Clinically Definite Multiple Sclerosis
Natalie J. Carter et al.
DRUGS (2010)
IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci
F. Esposito et al.
GENES AND IMMUNITY (2010)
Differential Gene Expression and Translational Approaches to Identify Biomarkers of Interferon Beta Activity in Multiple Sclerosis
Ed Croze
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Interferon-β mechanisms of action in multiple sclerosis
Suhayl Dhib-Jalbut et al.
NEUROLOGY (2010)
MxA A biomarker for predicting multiple sclerosis disease activity
Anthony T. Reder
NEUROLOGY (2010)
Cross-sectional study assessing long-term safety of interferon-β-1b for relapsing-remitting MS
A. T. Reder et al.
NEUROLOGY (2010)
Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-β-1b treatment in relapsing remitting MS
Robert H. Goertsches et al.
PHARMACOGENOMICS (2010)
IFN-β pharmacogenomics in multiple sclerosis
Koen Vandenbroeck et al.
PHARMACOGENOMICS (2010)
The Challenge of Multiple Sclerosis: How Do We Cure A Chronic Heterogeneous Disease?
Howard L. Weiner
ANNALS OF NEUROLOGY (2009)
Synergistic benefit in inflammatory arthritis by targeting IκB kinase ε and interferon β
M. Corr et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
M. Comabella et al.
BRAIN (2009)
The Protein Kinase IKKε Regulates Energy Balance in Obese Mice
Shian-Huey Chiang et al.
CELL (2009)
Molecular Mechanisms of Nrf2-Mediated Antioxidant Response
Wenge Li et al.
MOLECULAR CARCINOGENESIS (2009)
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score
Philip L. De Jager et al.
LANCET NEUROLOGY (2009)
Pharmacogenomics of IFN-beta in multiple sclerosis: towards a personalized medicine approach
Saskia Vosslamber et al.
PHARMACOGENOMICS (2009)
OLA1, an Obg-like ATPase, suppresses antioxidant response via nontranscriptional mechanisms
Jiawei Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The Nrf2-ARE Pathway An Indicator and Modulator of Oxidative Stress in Neurodegeneration
Jeffrey A. Johnson et al.
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS (2008)
IFN-β1b induces transient and variable gene expression in relapsing-remitting multiple sclerosis patients independent of neutralizing antibodies or changes in IFN receptor RNA expression
Anthony T. Reder et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2008)
IFN-β-regulated genes show abnormal expression in therapy-naive relapsing-remitting MS mononuclear cells:: Gene expression analysis employing all reported protein-protein interactions
Ken D. Yamaguchi et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity
R. E. Gonsette
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Pharmacogenomics of Interferon-β Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients
Lisa G. M. van Baarsen et al.
PLOS ONE (2008)
Effect of immunomodulation with human interferon-β on early functional recovery from experimental spinal cord injury
Beril Gok et al.
SPINE (2007)
Multiple functions of the IKK-related kinase IKKε in interferon-mediated antiviral immunity
Benjamin R. tenOever et al.
SCIENCE (2007)
The relationship between MRI and PET changes and cognitive disturbances in MS
PS Sorensen et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Free radicals-mediated damage in transmitochondrial cells harboring the T14487C mutation in the ND6 gene of mtDNA
R Gonzalo et al.
FEBS LETTERS (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Therapeutic stimulation of the hypothalamus: pathophysiological insights and prerequisites for management
M Leone et al.
BRAIN (2005)
Ketone body synthesis in the brain:: possible neuroprotective effects
M Guzmán et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2004)
A global test for groups of genes: testing association with a clinical outcome
JJ Goeman et al.
BIOINFORMATICS (2004)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1
X Feng et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Molecular cloning and characterization of two novel retinoic acid-inducible orphan G-protein-coupled receptors (GPRC5B and GPRC5C)
MJ Robbins et al.
GENOMICS (2000)